{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2020:OO73SI5Q5R6G4UXDMIGYJWVOHL","short_pith_number":"pith:OO73SI5Q","schema_version":"1.0","canonical_sha256":"73bfb923b0ec7c6e52e3620d84daae3afae83299caaa7305e210b6e824d0a375","source":{"kind":"arxiv","id":"2008.05377","version":1},"attestation_state":"computed","paper":{"title":"Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["q-bio.MN"],"primary_cat":"q-bio.QM","authors_text":"Anurag Verma, Brian Lee, Dokyoon Kim, Jae-Seung Yun, Ji Won Park, Li Shen, Seung Mi Lee, Xia Ning, Yonghyun Nam, Ziqi Chen","submitted_at":"2020-08-12T15:19:11Z","abstract_excerpt":"Currently, the number of patients with COVID-19 has significantly increased. Thus, there is an urgent need for developing treatments for COVID-19. Drug repurposing, which is the process of reusing already-approved drugs for new medical conditions, can be a good way to solve this problem quickly and broadly. Many clinical trials for COVID-19 patients using treatments for other diseases have already been in place or will be performed at clinical sites in the near future. Additionally, patients with comorbidities such as diabetes mellitus, obesity, liver cirrhosis, kidney diseases, hypertension, "},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2008.05377","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.QM","submitted_at":"2020-08-12T15:19:11Z","cross_cats_sorted":["q-bio.MN"],"title_canon_sha256":"113d7ccad8c7e0d83a3c0456d53d02e945353d5a35a24e3ed9ac6ff355653d16","abstract_canon_sha256":"4462593ad75e820f0bd3a269848647e2c449559f3ead6348bb1495a314eaa1ff"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T01:26:46.166178Z","signature_b64":"jfp/qXJTRPVO+tyugWD+IeYyI5sb691w3Yy5gQNaMlnzTHEAtVPkc1oHJUdgcQ7yuCADsfcW3+cXJOuqjT2KAg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"73bfb923b0ec7c6e52e3620d84daae3afae83299caaa7305e210b6e824d0a375","last_reissued_at":"2026-07-05T01:26:46.165799Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T01:26:46.165799Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["q-bio.MN"],"primary_cat":"q-bio.QM","authors_text":"Anurag Verma, Brian Lee, Dokyoon Kim, Jae-Seung Yun, Ji Won Park, Li Shen, Seung Mi Lee, Xia Ning, Yonghyun Nam, Ziqi Chen","submitted_at":"2020-08-12T15:19:11Z","abstract_excerpt":"Currently, the number of patients with COVID-19 has significantly increased. Thus, there is an urgent need for developing treatments for COVID-19. Drug repurposing, which is the process of reusing already-approved drugs for new medical conditions, can be a good way to solve this problem quickly and broadly. Many clinical trials for COVID-19 patients using treatments for other diseases have already been in place or will be performed at clinical sites in the near future. Additionally, patients with comorbidities such as diabetes mellitus, obesity, liver cirrhosis, kidney diseases, hypertension, "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2008.05377","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2008.05377/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2008.05377","created_at":"2026-07-05T01:26:46.165854+00:00"},{"alias_kind":"arxiv_version","alias_value":"2008.05377v1","created_at":"2026-07-05T01:26:46.165854+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2008.05377","created_at":"2026-07-05T01:26:46.165854+00:00"},{"alias_kind":"pith_short_12","alias_value":"OO73SI5Q5R6G","created_at":"2026-07-05T01:26:46.165854+00:00"},{"alias_kind":"pith_short_16","alias_value":"OO73SI5Q5R6G4UXD","created_at":"2026-07-05T01:26:46.165854+00:00"},{"alias_kind":"pith_short_8","alias_value":"OO73SI5Q","created_at":"2026-07-05T01:26:46.165854+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL","json":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL.json","graph_json":"https://pith.science/api/pith-number/OO73SI5Q5R6G4UXDMIGYJWVOHL/graph.json","events_json":"https://pith.science/api/pith-number/OO73SI5Q5R6G4UXDMIGYJWVOHL/events.json","paper":"https://pith.science/paper/OO73SI5Q"},"agent_actions":{"view_html":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL","download_json":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL.json","view_paper":"https://pith.science/paper/OO73SI5Q","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2008.05377&json=true","fetch_graph":"https://pith.science/api/pith-number/OO73SI5Q5R6G4UXDMIGYJWVOHL/graph.json","fetch_events":"https://pith.science/api/pith-number/OO73SI5Q5R6G4UXDMIGYJWVOHL/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL/action/timestamp_anchor","attest_storage":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL/action/storage_attestation","attest_author":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL/action/author_attestation","sign_citation":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL/action/citation_signature","submit_replication":"https://pith.science/pith/OO73SI5Q5R6G4UXDMIGYJWVOHL/action/replication_record"}},"created_at":"2026-07-05T01:26:46.165854+00:00","updated_at":"2026-07-05T01:26:46.165854+00:00"}